CP and complement 3 glomerulopathy: Similar to the case of the aHUS patient carrying the S250C mutation in C2 (2), there are reports of C4NeF autoantibodies stabilizing CP/LP convertases as a sole, potentially pathogenic factor identified in patients with C3 glomerulopathies (12, 13).